There are contradictory lab reports of Propofol injections, manufactured by Kala Amb-based Nixi Laboratories Private Limited. The Kolkata-based Central Drug Laboratory (CDL) recently declared the samples had passed the sterility test while the Chandigarh-based Regional Drugs Testing Laboratory had s
The Drugs Control Administration (DCA) has directed a pharmaceutical company at Kala Amb in Himachal’s Sirmaur district to stop manufacturing controversial injection Propofol following lab reports that it did not conform to the India Pharmacopoeia (IP) 2018 monograph nor met the quality standa